Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men

K Matyka1, M Evans, J Lomas

  • 1Department of Medicine, King's College School of Medicine and Dentistry, London, U.K.

Diabetes Care
|February 1, 1997
PubMed
Abstract

Insights

Older men experience more severe cognitive impairment during hypoglycemia and lack warning symptoms. This age-related decline increases risks for older diabetic patients undergoing glucose-lowering treatments.

Area of Science:

  • Endocrinology
  • Gerontology
  • Neuroscience

Background:

  • Type II diabetes is prevalent in aging populations.
  • Diabetes treatment can lead to hypoglycemia, a condition associated with cognitive impairment.
  • Normal aging's impact on hypoglycemia responses is not fully understood.

Purpose of the Study:

  • To investigate how normal aging affects protective responses to hypoglycemia.
  • To assess the relationship between aging, hypoglycemia, and cognitive function.

Main Methods:

  • 14 men (7 young, 7 older) underwent controlled intravenous insulin infusion to induce stepwise hypoglycemia.
  • Neurohumoral, subjective awareness, and cognitive responses (choice reaction time) were measured.
  • Plasma glucose levels were monitored throughout the infusion.

Main Results:

  • Hormonal responses to hypoglycemia were similar between age groups.
  • Younger men reported earlier and more intense hypoglycemic symptoms.
  • Older men showed earlier and greater deterioration in cognitive function (reaction time) and lost the warning symptom-to-cognitive dysfunction gap.

Conclusions:

  • Older men are more susceptible to severe cognitive impairment during hypoglycemia.
  • Aging diminishes the ability to perceive hypoglycemia, increasing risks for older individuals.
  • These findings highlight potential risks for older diabetic patients treated with insulin or sulfonylureas.

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...